viral
influenza
season
infect
associ
signific
morbid
mortal
unit
state
death
hospit
due
influenza
occur
annual
number
increas
children
age
less
year
adult
age
year
pregnant
woman
peopl
age
comorbid
ill
highest
risk
annual
vaccin
cornerston
prevent
older
patient
may
deriv
less
benefit
immun
otherwis
fit
individu
start
promptli
antivir
medic
may
reduc
complic
acut
influenza
increas
resist
amantadin
perhap
neuraminidas
inhibitor
underscor
need
novel
prevent
treatment
strategi
pulmonari
complic
influenza
common
includ
primari
influenza
secondari
bacteri
infect
either
may
caus
pneumonia
uniqu
clinic
present
patholog
basi
staphylococcu
aureu
includ
methicillinresist
strain
import
caus
secondari
bacteri
pneumonia
high
mortal
influenza
season
treatment
pneumonia
includ
empir
coverag
pathogen
neuromuscular
cardiac
complic
unusu
may
manifest
person
age
viral
influenza
wellestablish
caus
season
ill
gener
character
acut
onset
fever
myalgia
respiratori
symptom
healthi
person
diseas
usual
resolv
inconsequenti
howev
influenza
estim
caus
death
hospit
annual
unit
state
although
mani
hospit
pneumonia
influenza
also
associ
gener
increas
admiss
pulmonari
cardiovascular
diseas
less
frequent
neuromuscular
complic
appreci
complic
influenza
spur
clinician
toward
aggress
attempt
prevent
treatment
influenza
rare
test
patient
admit
hospit
pneumonia
case
relat
influenza
secondari
bacteri
pneumonia
rather
primari
influenza
pneumonia
estim
hospit
mortal
rate
model
compar
outcom
pneumonia
influenza
respiratori
circulatori
diseas
month
influenza
circul
rate
rest
winter
basi
methodolog
hospit
attribut
influenza
vari
depend
durat
season
predomin
strain
recent
influenza
seem
mildest
influenza
b
intermedi
influenza
sever
account
hospit
per
person
respect
death
due
influenza
although
estim
influenza
mortal
indirect
remark
consist
differ
model
compar
demonstr
increas
mortal
past
year
one
explan
rapid
age
us
popul
mortal
rate
person
age
year
time
greater
person
age
year
similarli
median
length
stay
increas
day
patient
year
old
day
year
old
assess
individu
risk
help
target
vaccin
normal
influenza
season
priorit
vaccin
shortag
chronic
medic
condit
heart
diseas
lung
diseas
diabet
renal
diseas
rheumatolog
diseas
dementia
stroke
risk
factor
influenza
complic
regardless
age
highrisk
condit
increas
rate
hospit
death
figur
thu
highrisk
patient
age
year
risk
equival
patient
age
year
high
incid
occult
cardiopulmonari
diseas
older
person
advisori
committe
immun
practic
extend
vaccin
recommend
includ
person
year
old
patient
age
year
highrisk
condit
particularli
danger
accord
one
clinic
predict
rule
highest
risk
demonstr
greater
risk
influenzarel
hospit
death
otherwis
healthi
elderli
person
group
risk
influenza
complic
includ
pregnant
immun
suppress
compar
nonpregn
women
high
lowrisk
pregnant
womenespeci
third
trimesterhav
cardiopulmonari
event
influenza
season
nevertheless
pregnant
women
low
vaccin
rate
report
vaccin
least
partial
relat
reluct
vaccin
part
obstetrician
influenza
import
caus
morbid
mortal
among
select
popul
alter
immun
respons
patient
human
immunodefici
syndrom
hiv
influenza
typic
clinic
present
fever
common
despit
vaccin
rate
durat
hospit
greater
hivinfect
person
mortal
infect
influenza
viru
influenc
progress
hiv
diseas
month
followup
organ
transplant
recipi
even
higher
risk
influenza
two
third
demonstr
either
viral
pneumonia
secondari
bacteri
pneumonia
relat
mortal
rate
influenza
also
trigger
allograft
reject
patient
one
studi
frequent
seriou
complic
influenza
pulmonari
fall
categori
primari
influenza
pneumonia
secondari
bacteri
pneumonia
pneumonia
due
unusu
pathogen
immunocompromis
host
exacerb
chronic
pulmonari
diseas
influenza
viru
common
caus
morbid
mortal
complic
influenza
includ
pneumonia
exacerb
underli
pulmonari
cardiac
diseas
young
elderli
comorbid
ill
highest
risk
annual
vaccin
cornerston
prevent
might
effect
elderli
antivir
therapi
adjunct
vaccin
highrisk
patient
first
conclus
evid
influenza
viru
could
caus
pneumonia
came
pandem
patient
primari
influenza
pneumonia
account
admit
hospit
evid
lower
respiratori
complic
influenza
age
year
underli
cardiac
diseas
present
classic
influenza
symptom
includ
high
fever
nonproduct
cough
myalgia
soon
appear
serious
ill
extrem
dyspnea
cyanosi
find
physic
examin
includ
diffus
rale
wheez
laboratori
studi
demonstr
leukocytosi
normal
erythrocyt
sediment
rate
bacteriolog
studi
neg
sputum
sampl
induc
bacteri
periton
inject
rodent
radiograph
reveal
diffus
infiltr
mimick
pulmonari
congest
mortal
interpandem
period
patient
influenza
pneumonia
like
underli
cardiopulmonari
diseas
mortal
patholog
find
pure
influenza
pneumonia
includ
necrot
bronchiti
hyalin
membran
intraalveolar
hemorrhag
edema
interstiti
inflammationchang
ident
seen
acut
respiratori
distresslik
syndrom
associ
influenza
pneumonia
recent
influenza
caus
viru
avian
flu
associ
larg
avian
epidem
spread
southeast
asia
case
report
human
victim
often
young
previous
healthi
person
fatal
rate
approxim
usual
due
respiratori
failur
spread
appear
primarili
bird
human
via
droplet
inhal
ill
occur
incub
day
initi
symptom
includ
high
fever
lower
respiratori
symptom
cough
may
product
common
hemoptysi
describ
sever
dyspnea
respiratori
distress
note
within
week
complet
blood
count
often
show
leucopenia
thrombocytopenia
common
xray
present
patchi
interstiti
infiltr
infrequ
pleural
effus
adult
respiratori
distress
syndrom
multiorgan
dysfunct
seen
patient
sever
ill
often
preced
death
postmortem
investig
confirm
death
commonli
associ
diffus
lung
injuri
vascular
congest
format
hyalin
membran
note
find
consist
primari
viral
pneumonia
rather
secondari
bacteri
complic
bacteri
pneumonia
complic
viral
influenza
report
pandem
multipl
subsequ
epidem
interepidem
period
typic
viral
influenza
infect
follow
near
resolut
symptom
subsequ
complic
day
later
recurr
fever
dyspnea
product
cough
pulmonari
consolid
common
pathogen
streptococcu
pneumonia
staphylococcu
aureu
haemophilu
influenza
occasion
gramneg
bacilli
aureu
pneumonia
follow
influenza
first
describ
pandem
strike
featur
includ
fulmin
cours
unusu
cyanosi
cherryr
indigoblu
lack
consolid
pulmonari
examin
dirti
salmonpink
purul
sputum
leucopenia
multipl
microabscess
autopsi
nearunivers
fatal
subsequ
report
confirm
increas
incid
aureu
pneumonia
epidem
staphylococc
toxic
shock
syndrom
aris
respiratori
tract
influenza
infect
also
describ
influenza
season
case
sever
communityacquir
pneumonia
due
methicillinresist
aureu
mrsa
report
mortal
mechan
bacteria
act
synergist
influenza
viru
includ
increas
bind
invas
bacteria
increas
viral
replic
modif
host
inflammatori
respons
interact
influenza
viru
bacteria
thoroughli
establish
streptococcu
pneumonia
viral
neuraminidas
cleav
sialic
acid
releas
new
viral
particl
host
cell
damag
epitheli
layer
airway
occur
expos
bind
site
necessari
adher
pneumococcu
multipl
report
describ
secondari
pneumonia
caus
less
common
microorgan
includ
aspergillu
sp
chlamydia
pneumonia
bhemolyt
streptococci
legionella
pneumophila
six
case
invas
aspergillosi
report
immunocompet
person
death
noninfecti
mimic
infect
may
incit
influenza
includ
bronchiol
obliteran
organ
pneumonia
usual
interstiti
pneumonia
transient
goodpastur
syndrom
influenzarel
bronchiol
obliteran
organ
pneumonia
describ
lung
transplant
recipi
associ
allograft
reject
goodpastur
syndrom
resolv
cure
influenza
although
rhinovirus
coronavirus
account
major
pathogen
exacerb
chronic
lung
diseas
influenza
also
may
account
much
mechan
influenza
viru
respiratori
virus
induc
exacerb
chronic
respiratori
diseas
incomplet
understood
like
relat
inflammatori
mediat
includ
interleukin
cytokin
modif
ratio
tcell
subset
lead
increas
sensit
allergen
addit
system
respiratori
effect
viral
influenza
pulmonari
complic
aris
direct
effect
influenza
viru
lung
viru
exert
direct
indirect
effect
bodi
system
myositi
rhabdomyolysi
rare
report
associ
either
influenza
b
one
studi
patient
hospit
influenza
note
elev
creatin
phosphokinas
demonstr
muscl
necrosi
biopsi
clinic
sever
vari
includ
renal
failur
problem
ambul
involv
proxim
leg
muscl
symptom
gener
resolv
week
neurolog
complic
influenza
includ
encephalopathi
rey
syndrom
encephalomyel
transvers
myeliti
asept
mening
focal
neurolog
disord
syndrom
central
nervou
system
involv
common
children
pathogenesi
includ
direct
viral
invas
develop
antigenantibodi
complex
often
uncertain
present
gener
rapid
mortal
may
reach
acut
necrot
encephalopathi
report
primarili
japan
commonli
associ
influenza
diseas
often
fulmin
fatal
diagnosi
central
nervou
system
involv
base
clinic
laboratori
find
lumbar
punctur
demonstr
elev
protein
lymphocyt
pleocytosi
comput
tomographi
magnet
reson
imag
scan
perform
case
focal
sever
neurolog
symptom
abnorm
predict
advers
outcom
rey
syndrom
acut
noninflammatori
encephalopathi
document
clinic
pictur
record
cerebrospin
fluid
contain
less
leukocytesmm
histolog
section
brain
demonstr
cerebr
edema
without
perivascular
mening
inflamm
associ
either
fatti
liver
b
elev
transaminas
serum
ammonia
correl
influenza
activ
exist
sever
decad
case
occur
white
children
less
year
age
confirm
adult
case
associ
primarili
influenza
result
death
case
annual
report
mortal
rate
incid
dramat
declin
past
decad
like
appreci
role
salicyl
causat
psychiatr
complic
influenza
infect
consid
controversi
sever
studi
note
increas
rate
schizophrenia
offspr
women
develop
influenza
second
trimest
pregnanc
impli
fetal
development
brain
abnorm
especi
relat
influenza
epidem
associ
influenza
season
although
influenza
frequent
exacerb
underli
heart
problem
congest
heart
failur
ischem
heart
diseas
direct
cardiac
complic
consid
uncommon
pericard
myocard
note
prospect
studi
abnorm
electrocardiograph
find
present
adult
without
cardiac
symptom
alter
seen
present
resolv
day
patient
muscl
damag
reduc
eject
fraction
influenza
pneumonia
seem
predispos
one
myocardi
infarct
congest
heart
failur
exacerb
common
influenza
season
given
tremend
health
econom
burden
influenza
prevent
ill
complic
public
health
concern
cornerston
prevent
remain
annual
vaccin
trival
kill
viru
vaccin
recommend
yearli
vaccin
adult
age
year
children
age
month
patient
age
chronic
medic
condit
women
pregnant
immunesuppress
patient
caretak
highrisk
patient
health
care
worker
healthi
adult
children
influenza
vaccin
prevent
influenza
ill
depend
adequaci
match
circul
viru
less
effect
prevent
influenzalik
ill
vaccin
also
may
modest
impact
work
loss
prevent
day
work
lost
per
worker
vaccin
even
consid
aggreg
trial
small
demonstr
reduct
influenza
complic
less
direct
evid
vaccin
efficaci
elderli
highrisk
patient
cochran
review
random
trial
includ
patient
demonstr
rate
vaccin
effect
influenza
influenzalik
ill
particip
age
year
seem
littl
efficaci
group
observ
cohort
studi
offer
conflict
data
elderli
individu
live
commun
million
patient
studi
vaccin
fail
protect
influenzalik
ill
influenza
pneumonia
associ
reduct
hospit
influenza
pneumonia
reduct
allcaus
mortal
vaccin
patient
older
comorbid
diseas
nonvaccin
patient
adjust
confound
vaccin
associ
reduc
risk
hospit
respiratori
diseas
odd
ratio
cardiac
diseas
odd
ratio
allcaus
mortal
odd
ratio
subset
patient
high
risk
complic
effect
vaccin
influenza
pneumonia
hospit
reduct
allcaus
mortal
reduct
allcaus
mortal
winter
month
challeng
sever
ground
first
antibodi
respons
elderli
patient
influenza
vaccin
blunt
tcell
respons
shortliv
second
unclear
vaccin
protect
influenza
pneumonia
death
respiratori
caus
reduc
allcaus
mortal
final
propos
vaccin
decreas
allcaus
winter
mortal
declin
notic
ageadjust
mortal
rate
proport
popul
vaccin
influenza
increas
season
domin
sever
strain
pneumonia
influenza
death
inde
declin
vaccin
level
increas
wherea
ageadjust
allcaus
mortal
remain
flat
one
explan
select
biasthat
frail
elderli
patient
highest
risk
death
less
like
vaccin
avail
administr
data
captur
frailti
inde
data
cohort
studi
demonstr
vaccin
highrisk
person
lower
mortal
influenza
season
adjust
diagnosi
code
variabl
affect
relationship
companion
casecontrol
studi
adjust
function
statu
identifi
chart
review
negat
mortal
effect
influenza
vaccin
wherea
adjust
diagnosi
code
enhanc
effect
vaccin
although
influenza
vaccin
undoubtedli
provid
benefit
elderli
research
need
done
way
improv
efficaci
older
person
potenti
method
includ
altern
mode
deliveri
immun
adjuv
strategi
indirect
protect
immun
famili
caregiv
greater
use
antivir
medic
immun
health
care
worker
particularli
import
influenza
common
group
often
unrecogn
vaccin
health
care
worker
associ
decreas
mortal
among
patient
longterm
care
facil
influenza
outbreak
medic
prevent
influenza
ill
lessen
symptom
prevent
complic
two
adamantan
amantadin
rimantadin
neuraminidas
inhibitor
oseltamivir
zanamivir
avail
unit
state
high
level
resist
amantadin
season
resist
increas
adamantan
current
recommend
resist
oseltamivir
report
japan
remain
low
worldwid
avian
influenza
may
resist
avail
agent
clinic
trial
antiinfluenza
medic
mostli
enrol
healthi
adult
children
agent
shorten
ill
approxim
day
treatment
must
start
within
hour
symptom
effect
start
within
hour
treatment
also
seem
effect
highrisk
patient
neuraminidas
inhibitor
decreas
antibiot
use
rate
lower
respiratori
tract
infect
pool
analys
oseltamivir
trial
demonstr
decreas
hospit
among
treat
patient
rel
placebo
averagerisk
highrisk
patient
studi
hospit
patient
clinic
trial
antiinfluenza
medic
avian
influenza
although
oseltamivir
zanamivir
appear
activ
avian
influenza
vitro
observ
studi
found
treat
untreat
patient
similar
mortal
resist
oseltamivir
report
vietnam
basi
ferret
model
earlier
treatment
higher
dose
might
improv
efficaci
oseltamivir
secondari
bacteri
pneumonia
treat
promptli
antibiot
recent
increas
rate
mrsa
pneumonia
influenza
infect
clinician
countri
mrsa
preval
strongli
consid
use
empir
vancomycin
anoth
antimicrobi
efficaci
mrsa
pend
bacteriolog
data
influenza
outbreak
occur
longterm
care
facil
despit
high
level
vaccin
season
prophylaxi
adamantan
neuraminidas
inhibitor
shown
prevent
new
case
influenza
ill
control
also
achiev
outbreak
detect
administ
prophylaxi
asymptomat
individu
adamantan
current
recommend
resist
futur
studi
may
examin
role
antivir
therapi
patient
hospit
complic
influenza
anoth
candid
indic
hmgcoa
reductas
inhibitor
statin
observ
trial
found
agent
reduc
risk
pneumonia
hospit
mortal
although
result
may
confound
healthi
user
effect
random
trial
need
given
pauciti
treatment
potenti
avail
pandem
flu
statin
may
lowcost
option
avail
countri
complic
viral
influenza
involv
numer
organ
system
appreci
risk
role
prevent
treatment
may
allow
time
manag
strategi
better
use
influenza
vaccin
antivir
may
decreas
risk
pulmonari
complic
novel
prevent
treatment
strategi
need
improv
outcom
highest
risk
new
strain
influenza
viru
emerg
